The antimicrobial catheter has been shown to kill a range of bacteria, including the hospital-acquired infection MRSA. The study also found that the device could protect patients for up to 100 days compared to current catheters. This is a huge breakthrough in dialysis treatment. The use of such catheter reduces the risk of these infections. Therefore, a patient's quality of life can be increased significantly.
Moreover, the increasing incidence of Catheter-associated Urinary Tract Infections is expected to drive market growth. According to research findings published in the Clinical Microbiology journal, 34 out of 1380 catheterized patients developed CAUTI. The antimicrobial-impregnated catheters are considered superior in the long run, as they are less likely to be contaminated by certain microorganisms. The market is likely to increase if there are more large-scale RCTs that are larger in scale.
In addition to reducing catheter-related BSIs, antimicrobial urinary catheters can also decrease the risk of bloodstream infections. However, in order to implement these devices into daily practice, randomized multicenter trials must be performed to establish their effectiveness. It is important to understand that the research and development of such catheters are advancing rapidly. But there are some challenges associated with the materials and socio-economics of these devices. These catheters are necessary for many patients. This technology helps them avoid catheter-related infections. It is a critical medical tool that can be used by many patients. In this way, it is essential for people to receive a blood-pressure monitor and receive an antibiotic. An antimicrobial catheter is a useful tool for patients with gastrointestinal tract infections. It is important for the patient because it is a vital part of the patient's body. It can prevent a host of other infections. The antimicrobial catheter is made of polyethylene and can be used to treat GI bleeding.
0 Comments